Skip to content
OpenCapital
Get started

Instil Bio TIL Q4 2025 Annual earnings

Reported March 27, 2026 · Before market open

Diluted EPS-$1.21Beat by $1.10
Revenue estimate$1.9M
EPS estimate-$2.31

Next report

Aug 12, 2026 (in a month)
EPS estimate-$0.35

Versus estimates

Diluted EPS

Q1 2026-$0.62In line
Q4 2025-$1.21Beat by $1.10
Q3 2025-$2.01Miss by $0.01Q2 2025-$3.24Miss by $1.52Q1 2025-$4.32Miss by $2.30Q4 2024-$1.82Beat by $1.93

Ask the moment Instil Bio reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Instil Bio report Q4 2025 earnings?
Instil Bio (TIL) reported Q4 2025 earnings on March 27, 2026 before market open.
What were Instil Bio's Q4 2025 revenue and EPS?
Instil Bio reported diluted EPS of $-1.21 for Q4 2025.
Did Instil Bio beat estimates in Q4 2025?
EPS beat the consensus estimate of $-2.31 by $1.10.
How did Instil Bio's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 33.5% from $-1.82.
Where can I find Instil Bio's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001789769-26-000018) and the 10-K periodic report (0001789769-26-000019) directly on SEC EDGAR. The filing index links above go to sec.gov.